JESÚS JERÓNIMO
PINTOR JUST
Ikertzailea 2019-(e)ra arte
JESÚS JERÓNIMO PINTOR JUST-rekin lankidetzan egindako argitalpenak (35)
2022
-
Therapeutic potential of topical administration of siRNAs against HIF-1α for corneal neovascularization
Experimental Eye Research, Vol. 219
2020
-
Optimization of a Rabbit Dry Eye Model Induced by Topical Instillation of Benzalkonium Chloride
Journal of Ophthalmology, Vol. 2020
2019
-
Effect of Melatonin and Its Analogs on Tear Secretion
The Journal of pharmacology and experimental therapeutics, Vol. 371, Núm. 1, pp. 186-190
2017
-
Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
Immunity and Ageing, Vol. 14, Núm. 1
-
The role and therapeutic potential of melatonin in age-related ocular diseases
Journal of Pineal Research, Vol. 63, Núm. 2
-
Understanding the presence and roles of Ap4A (Diadenosine tetraphosphate) in the eye
Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 6, pp. 426-434
2016
-
The role of dinucleoside polyphosphates on the ocular surface and other eye structures
Progress in Retinal and Eye Research, Vol. 55, pp. 182-205
2015
-
Effect of melatonin and analogues on corneal wound healing: Involvement of Mt<inf>2</inf> melatonin receptor
Current Eye Research, Vol. 40, Núm. 1, pp. 56-65
-
Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells
Journal of Pharmacology and Experimental Therapeutics, Vol. 352, Núm. 1, pp. 119-128
-
Signs and symptoms of dry eye in keratoconus patients: A pilot study
Current Eye Research, Vol. 40, Núm. 11, pp. 1088-1094
2014
-
An update on dry eye disease molecular treatment: Advances in drug pipelines
Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 10, pp. 1371-1390
2013
-
Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: Significance for combination therapy in glaucoma
Journal of Pharmacology and Experimental Therapeutics, Vol. 346, Núm. 1, pp. 138-145
2012
-
Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT
Journal of Pineal Research, Vol. 52, Núm. 3, pp. 265-270
-
Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential
Expert Opinion on Drug Discovery, Vol. 7, Núm. 10, pp. 989-1001
-
Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 2, pp. 89-98
-
Recent patents and developments in glaucoma biomarkers
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 3, pp. 224-234
-
Silencing of P2Y 2 receptors reduces intraocular pressure in New Zealand rabbits
British Journal of Pharmacology, Vol. 165, Núm. 4 B, pp. 1163-1172
-
Update in glaucoma medicinal chemistry: Emerging evidence for the importance of melatonin analogues
Current Medicinal Chemistry, Vol. 19, Núm. 21, pp. 3508-3522
2011
-
Phospholipase C/protein kinase C pathway is essential for corneal re-epithelialization induced by Ap 4A
Current Eye Research, Vol. 36, Núm. 12, pp. 1108-1115
-
Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: Implications for glaucoma treatment
Pharmacogenetics and Genomics, Vol. 21, Núm. 9, pp. 587-589